X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JAPANESE JOURNAL OF CLINICAL ONCOLOGY

期刊標題檢索 JPN J CLIN ONCO 最新評論: Waiting for the chief editor's decision refers to the status where the... (2024-09-18)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JAPANESE JOURNAL OF CLINICAL ONCOLOGY]您好,您是該頁面的第 40880 位訪客。

期刊簡介
期刊名稱JAPANESE JOURNAL OF CLINICAL ONCOLOGY JAPANESE JOURNAL OF CLINICAL ONCOLOGY
LetPub Score
5.3
50 ratings
Rate

Reputation
6.4

Influence
4.0

Speed
7.1

期刊簡稱JPN J CLIN ONCOL
ISSN0368-2811
E-ISSN1465-3621
h-index79
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.700.6120.799
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q2144 / 333
Category: Medicine
Subcategory: Oncology
Q3222 / 404
Category: Medicine
Subcategory: Cancer Research
Q3163 / 230

自引率 (2023-2024)15.80%自引率趨勢
掲載範囲
Japanese Journal of Clinical Oncology is a multidisciplinary journal for clinical oncologists which strives to publish high quality manuscripts addressing medical oncology, clinical trials, radiology, surgery, basic research, and palliative care. The journal aims to contribute to the world"s scientific community with special attention to the area of clinical oncology and the Asian region.

JJCO publishes various articles types including:
・Original Articles
・Case Reports
・Clinical Trial Notes
・Cancer Genetics Reports
・Epidemiology Notes
・Technical Notes
・Short Communications
・Letters to the Editors
・Solicited Reviews
官方網站https://academic.oup.com/jjco
在線稿件提交http://mc.manuscriptcentral.com/jjco
開放訪問No
出版商Oxford University Press
主題領域医学
出版國/地區JAPAN
發行頻率月刊
創刊年1971
每年文章數155每年文章數趨勢
黃金OA百分比17.38%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3234/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0368-2811%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【JAPANESE JOURNAL OF CLINICAL ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS330481
    CANCER RESEARCH312115
    BMC CANCER245373
    Asian Pacific Journal of Cancer Prevention218891
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198010
    INTERNATIONAL JOURNAL OF CANCER191596
    CLINICAL CANCER RESEARCH181651
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176061
    ONCOLOGY REPORTS174987
    CA-A CANCER JOURNAL FOR CLINICIANS163624
  •  

    JAPANESE JOURNAL OF CLINICAL ONCOLOGY JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [JAPANESE JOURNAL OF CLINICAL ONCOLOGY] 的評論撰寫評論
作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 22:42:23 評論於
Waiting for the chief editor's decision refers to the status where the editor has consolidated all the opinions of the reviewers and the chief editor makes the final decision.
(0) 讚! | Adelaide Lawson

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 13:46:02 評論於
Good luck, the decision from the chief editor is not far away, please be patient and wait.
(0) 讚! | Adelaide Lawson

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 08:37:16 評論於
While waiting for the editor-in-chief to make a decision, the next stage is not far off. Pay close attention to the status of your submission.
(0) 讚! | Adelaide Lawson

作者: Julius Sinclair


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-16 18:42:48 評論於
A few days ago I was awaiting AE decision, today it has changed to awaiting EIC decision. Nervous.
(0) 讚! | Julius Sinclair

作者: Julius Sinclair


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-16 12:46:26 評論於
Hello, I would like to ask what does the status "waiting EIC decision" mean?
(0) 讚! | Julius Sinclair

作者: Julius Sinclair


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-16 08:25:41 評論於
After AE's decision, it has been changed to "awaiting EIC decision". Is there a high possibility of being hired, or will it require revisions?
(0) 讚! | Julius Sinclair

作者: Julius Sinclair


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-15 08:15:23 評論於
Today I saw that it has already been Waiting AE recommendation, please accept ??
(0) 讚! | Julius Sinclair

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-01 22:52:58 評論於
The review period of this journal is generally around 3-8 weeks. You are only about 2 weeks in, so being "Under Review" is within the normal range.
(0) 讚! | Adelaide Lawson

作者: Julius Sinclair


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-01 19:47:02 評論於
What does it mean when it says "under review" after submitting, with three EO written? Is it under review or still in the hands of the editor?
(0) 讚! | Julius Sinclair

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-01 12:42:45 評論於
This may indicate that the editor has invited three reviewers to evaluate your manuscript, but does not mean it has been sent out for external peer review.
(0) 讚! | Adelaide Lawson

作者: Julius Sinclair


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-27 20:30:13 評論於
Research focus: Tumors; Cancer
Experience sharing: Submitted on August 19, 2024, still under review, with 3 reviewers.
(0) 讚! | Julius Sinclair

作者: 木子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-04 17:39:17 評論於
Is there a charge for this?
(0) 讚! | 木子

作者: Jiang Huihui


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2024-06-22 19:30:48 評論於
Rejected after major revision, the magazine said their acceptance rate is only 20%.
(0) 讚! | Jiang Huihui

作者: 思茵来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-02 12:12:16 評論於
Please translate the following paragraph into English: 接accept
(0) 讚! | 思茵来了

作者: 北风成文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-03 17:00:54 評論於
Where has the author submitted now?
(0) 讚! | 北风成文

作者: 小新真吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-26 16:46:52 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0 
Research focus: Nutrition; Experience sharing in gastrointestinal surgery: 4.19 submit 6.11 minor revision 8.3 major revision 8.24 minor revision 8.25 major revision 9.25 acceptance. During the process, the status of "awaiting AE recommendation" is most common, and the efficiency is generally average
(0) 讚! | 小新真吖

作者: 一条小友容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-28 11:41:29 評論於
Have you repeatedly received the following emails when returning for rework?
(0) 讚! | 一条小友容

作者: 一条小友容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-28 10:28:38 評論於
Can I ask why we always receive emails saying the quality inspection is not correct when we send items for repair?
(0) 讚! | 一条小友容

作者: 白云又菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-24 23:52:55 評論於
Submitted a case, was rejected decisively... They said the priority level of the article was not enough. It's so hard to submit cases now, either it's a journal that gets flagged for warnings, or it's not SCI, or it's a comprehensive journal that can only publish a few cases a year, mostly domestic cases... I really don't understand why they flagged world cases... It's making it so difficult to submit cases
(0) 讚! | 白云又菡

作者: 孤云静晨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-25 10:44:37 評論於
It has been almost a month and I am still crying in AE
(0) 讚! | 孤云静晨

作者: 重阳庆庆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-22 09:40:18 評論於
+1, do you accept meta?
(0) 讚! | 重阳庆庆

作者: Miranda


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-18 10:41:20 評論於
Focused Research Area: Cancer; Tumor Experience Sharing: Are there any experts willing to share their experiences on submitting to this journal?
(0) 讚! | Miranda

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:32:45 評論於
The title of the paper should be concise and not too long. The shorter the better, while accurately reflecting and clearly expressing the most important specific content. Try to avoid unnecessary words, delete excess words as much as possible. Short paper titles generally have higher citation rates
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:51:48 評論於
Today is a beautiful day, I will go for a walk in the park
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 23:29:03 評論於
How many words are usually required for the title of an article?
(0) 讚! | 陶宜三岁啦

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [JAPANESE JOURNAL OF CLINICAL ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*